Advertisement

Topics

Novo bests Lilly in diabetes trial, but will that lead to market advantage?

05:12 EDT 17 Aug 2017 | BioPharmaDive

With the diabetes space already crowded, some investors are questioning whether the Danish drugmaker's semaglutide can secure market share.

Original Article: Novo bests Lilly in diabetes trial, but will that lead to market advantage?

NEXT ARTICLE

More From BioPortfolio on "Novo bests Lilly in diabetes trial, but will that lead to market advantage?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...